Clinical Trials
12 trialsNCT07617493 2026-06-01
Evaluation of ICP-B208 in Patients With Advanced Solid Tumors
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2 Not yet recruiting
NCT07615660 2026-05-29
CVL006-T1003
Convalife (Shanghai) Co., Ltd.
Phase 1/2 Not yet recruiting
NCT07587879 2026-05-14
mRNA-LNP
IntraAb, Inc.
Phase 1/2 Not yet recruiting
NCT07512583 2026-04-06
Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Not yet recruiting
NCT07508761 2026-04-02
IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors
Nanjing Immunophage Biotech Co., Ltd
Phase 1/2 Not yet recruiting
NCT07339748 2026-01-15
A Clinical Study of ZL-85FA Tablets
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 1/2 Not yet recruiting
NCT07157956 2025-09-05
CVL006-T1002
Convalife (Shanghai) Co., Ltd.
Phase 1/2 Not yet recruiting
NCT07142837 2025-08-27
Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2 Not yet recruiting
NCT06970132 2025-05-14
Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation
Shouyao Holdings (Beijing) Co. LTD
Phase 1/2 Not yet recruiting
NCT06144723 2023-11-22
Study of HS-20105 for Injection in Patients With Advanced Solid Tumors.
Hansoh BioMedical R&D Company
Phase 1/2 Not yet recruiting
NCT06132217 2023-11-15
A Study of Simmitinib Plus SG001 in Advanced Solid Tumors
Shanghai Runshi Pharmaceutical Technology Co., Ltd
Phase 1/2 Not yet recruiting
NCT05642949 2023-01-09
Study of MHB036C in Participants With Advanced or Metastatic Solid Tumors
Minghui Pharmaceutical Pty Ltd
Phase 1/2 Not yet recruiting